Agile Therapeutics to Present at 29th Annual ROTH Conference
02 3월 2017 - 6:10AM
Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty
pharmaceutical company announced today that its Chief Executive
Officer, Al Altomari will present at 29th Annual ROTH Conference on
Monday, March 13, 2017 at 4:30 PM Pacific Time. The conference is
being held at the Ritz Carlton Hotel in Dana Point, CA.
To access the live and archived webcasts of the
presentation, visit the Investor Relations section of the Agile
Therapeutics website at www.agiletherapeutics.com. The
webcast will be archived on Agile Therapeutics website for 60 days
following the event.
About Agile Therapeutics
Agile Therapeutics is a forward-thinking
women's healthcare company dedicated to fulfilling the unmet health
needs of today's women. Our product candidates are designed to
provide women with contraceptive options that offer freedom
from taking a daily pill, without committing to a
longer-acting method. Our lead product candidate, Twirla®,
(ethinyl estradiol and levonorgestrel transdermal system), also
known as AG200-15, is a once-weekly prescription contraceptive
patch that recently completed Phase 3 trials. Twirla is based
on our proprietary transdermal patch technology, called
Skinfusion®, which is designed to provide advantages over currently
available patches and is intended to optimize
patch adhesion and patient wearability. For more
information, please visit the company website at
www.agiletherapeutics.com.
Contact: Mary Coleman 609-683-1880
Agile Therapeutics (NASDAQ:AGRX)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Agile Therapeutics (NASDAQ:AGRX)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024